#Rethink your HCP strategy: MS-based analysis under GMP

March 29 2022

Monitor HCP clearance for expression systems without access to an ELISA kit

Now you can rethink your HCP assay strategy with mass spectrometry (MS)-based HCP analysis available from a GMP-certified lab. It is ideal when there is no sufficient generic ELISA for your cell line – or when the time to develop a process-specific ELISA is limited, e.g., for phase 2 and 3 clinical trials.

An MS-based assay has very high HCP coverage and sensitivity and is customizable within weeks. It even enables the identification and quantification of individual HCPs – for instance, across batches for easy comparison of purification strategies. The assay is available for full validation following ICH guidelines and thus accessible for release testing and commercial production.

Learn more and sign up here >>